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Abstract
Background: Fluralaner spot-on solution provides immediate and persistent efficacy against tick and flea infestations in
dogs and cats for 12-weeks following topical administration. The active ingredient fluralaner is distributed systemically
following transdermal absorption. Therefore, this study tested the hypothesis whether water-immersion or shampooing of
dogs following administration of fluralaner spot-on solution has an impact on subsequent tick and flea efficacy.
Methods: Thirty-two Beagle dogs were allocated to four study groups of 8 dogs each. On day 0, dogs in the 2 treatment
groups received topical administration of fluralaner (Bravecto™ spot-on solution) according to label instructions. Dogs in
the 2 corresponding control groups remained untreated. On days 3, 21, 49, and 77 dogs in one treatment group and
control group were water-immersed for 2–5 min, while dogs in the other treatment group and control group were
shampooed 6–8 min with a commercial foaming micro-emulsion, unscented product. On days 4, 28, 56, and 84 all dogs
were co-infested with 50 ± 2 female and 10 ± 2 male Ixodes ricinus and 100 ± 4 Ctenocephalides felis, with tick and flea
removal and counts 48 ± 2 h post-infestation. Efficacy against ticks and fleas was calculated for each assessment time
point.
Results: No treatment-related adverse event was observed in any of the 16 dogs treated with fluralaner spot-on solution
during the study.
Efficacy against ticks at each assessment time point was between 99.7 and 100 % in the water-immersed group and
between 99.2 and 100 % in the shampooed group. Efficacy against fleas was 100 % at each assessment time point as
well in the water-immersed as the shampooed group. Tick and flea reduction in both treatment groups was significant at
all assessment time points (p< 0.0001).
Conclusions: Neither water-immersion nor shampooing after single topical administration of fluralaner spot-on solution
had an impact on the excellent tick and flea efficacy over the 12-week recommended re-treatment interval.
Keywords: Bathing, Bravecto™ spot-on solution, Fluralaner, Dog, Flea, Ctenocephalides felis, Efficacy, Water-immersion,
Shampooing, Tick, Ixodes ricinus
Background
Ticks and fleas are the most important ectoparasites infest-
ing dogs worldwide. They cause discomfort and blood loss
for infested dogs and also create concerns for owners when
their pets are infested. Furthermore, there is risk for
secondary complications such as flea allergy dermatitis
(FAD) [1], and transmission of pathogens via blood-feeding
parasites [2, 3]. Thus, tick and flea control for dogs con-
tinues to be of great medical and veterinary importance.
During the last decade the number of products and
strategies available for tick and flea control increased re-
markably, e.g. by combining several active ingredients into
one formulation to broaden the anti-parasitic spectrum,
or presenting different routes of administration, including
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oral, injectable and topical administration, giving the vet-
erinarian and pet owner the option of choosing their pre-
ferred product [4, 5].
Products with a topical route of administration can po-
tentially have their duration and level of efficacy affected by
water (i.e. rainfall or swimming) or owner practices (i.e.
shampooing of the dog). For example, some dogs (e.g. those
with an outdoor or working lifestyle) may get a lot of water
exposure and/or owners may frequently bathe their dog for
cosmetic or health reasons. Water exposure can markedly
shorten the period of flea effectiveness of imidacloprid and
flumethrin administered topically in a collar presentation
[6]. Therefore, for a topically administered ectoparasiticide
it is important to ensure that the treatment maintains its ef-
fectiveness over the entire recommended treatment interval
including the possibility of repeated water-immersion or
shampooing.
Bravecto™, with its active ingredient fluralaner, is com-
mercially available as a flavoured chewable tablet [7]
and also more recently as a topical solution [8]. In both
formulations, fluralaner is distributed systemically and
ectoparasites are exposed through feeding activity. Both
chewable and topical presentations have demonstrated
an efficacy duration of 12 weeks and provide immediate
and persistent killing of ticks and fleas on dogs. As flur-
alaner spot-on solution is administered topically and
distributed systemically following transdermal absorp-
tion, it is hypothesized that bathing or shampooing a
treated dog will have no impact on the subsequent tick
and flea killing efficacy. Thus, the aim of this study was
to evaluate this hypothesis by assessing the potential ef-
fect of water-immersion (simulating swimming of the
dog) and the potential effect of shampooing on the per-
sistent tick and flea killing efficacy after a single adminis-
tration of fluralaner spot-on solution to dogs.
Methods
Study set-up
The study was conducted in accordance with Good Clin-
ical Practice (VICH guideline GL9, Good Clinical Practice,
EMA, 2000), and was in compliance with the Statutory
Instrument S.I. No. 566 of 2002, which incorporates EC
directive, 86/609/EC into Irish law. The study was submit-
ted to the Ethics Committee of Charles River Laboratories
Preclinical Services Ireland Ltd that authorized the con-
duct of the study. The study was performed as a negative
controlled, blinded, randomized efficacy study.
In total, 32 Beagles (16 males, 16 females) with an intact
hair coat at the administration site (i.e., dorsal back re-
gion), over 6 months of age and weighing between 8.1 and
18.9 kg were included. Each dog was in good health, had
not been treated with any parasite control product within
3 months prior to an 8 day acclimatization period, and
was uniquely identified by a microchip number.
Prior to randomization, dogs were clinically examined
and the parasite susceptibility of each dog was confirmed
by a flea infestation with 100 (±4) unfed adult Ctenoce-
phalides felis fleas followed by flea removal and count
48 h (±2 h) later. The flea isolate used in the study
originated from the University of Cardiff, United
Kingdom, and has been maintained since 1996, with the
last outside introduction in August 2004, at Charles
River Laboratories Preclinical Services Ireland Ltd. All
dogs included in the study harboured more than 50 % of
the number of originally infested fleas. Ranking of the
dogs was performed within gender by descending flea
counts and dogs were randomly allocated to 4 study
groups (2 treatment and 2 control groups, each for water
immersion or shampooing) of 8 dogs each using a com-
puter generated randomization list.
All dogs were kept indoors. During periods without
parasite infestation, dogs were group-housed within their
corresponding study group, while during periods of
parasite infestations, all dogs were housed individually.
On days of individual housing and without any activities
that involved interaction with the dog, each dog had so-
cial interaction for a minimum of 2 min. Social inter-
action included either rubbing, talking to or playing with
the animal in its pen.
Temperature in the dog housing facility ranged be-
tween 16 and 20 °C and the relative humidity between
38 and 73 %. Dogs were fed a standard commercially
available dry dog food once daily, and drinking water
was provided ad libitum. General health observations
were performed once daily throughout the study.
Treatment
On day 0 (i.e., day of treatment), dogs in the 2 treatment
groups were treated once topically with fluralaner
(Bravecto™ spot-on solution) according to the manufac-
turer’s label instructions. Before administration, the skin
and hair of the designated administration sites were
inspected visually for any abnormalities, which were not
observed. Fluralaner spot-on solution was administered
topically as one or two spots along the dog’s dorsal line de-
pending on the administration volume. The first spot was
administered between the shoulder blades and the second
spot approximately 5–10 cm caudal of the previous spot.
The hair was parted and the tip of the pipette was placed
vertically on the skin and the solution administered directly
to the skin by pressing the corpus of the pipette to empty
its contents. After administration, the dog was held upright
for approximately 5 min to determine, if any of the solution
ran off the animal during or directly (up to 5 ± 2 min) after
treatment. There was no evidence of mis-dosing such as
spillage or run-off/drip-off in any treated animal. Dogs in
both control groups remained untreated.
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Water-immersion and shampooing of dogs
On days 3, 21, 49, and 77 after treatment, dogs of one
treatment group were water-immersed and dogs of the
other treatment group were shampooed using a locally
procured commercial foaming micro-emulsion and un-
scented shampoo without any insecticide for dogs (Aller-
myl® shampoo, Virbac Animal Health, France). Dogs of
the corresponding control group were either water-
immersed or shampooed, respectively, at the same de-
fined times after treatment as dogs in the corresponding
treatment group. For water-immersion, each dog was
water immersed for 2 – 5 min in a separate tank of fresh
lukewarm water while holding the head of the dog out
of the water. The head was wetted by pouring water over
it. For shampooing (lasted 6–8 min), the entire body of
each dog was first wetted with lukewarm water. Then
15–20 mL of shampoo was applied to the entire body
(avoiding the nose and eyes region). The dog’s hair coat
was massaged until foam formation. Thereafter, the dog
was rinsed thoroughly with fresh lukewarm water to re-
move all residual shampoo. After water-immersion or
shampooing, each dog was dried with a separate towel
and then air dried.
Co-infestations with ticks and fleas and their assessments
The tick isolate used in the study originated from
Slovakia, Germany and Ireland, and has been maintained
since 2004, with annual refreshments, at Charles River
Laboratories Preclinical Services Ireland Ltd. Tick and
flea co-infestations were conducted on ketamine/xyla-
zine sedated dogs on days 4, 28 (4 weeks), 56 (8 weeks),
and 84 (12 weeks) after treatment. At each infestation
time point each dog was co-infested with 100 (±4) unfed
adult C. felis fleas and 60 (±4) viable unfed adult I. rici-
nus ticks (50 ± 2 females and 10 ± 2 males). The 10 male
ticks were additionally applied to give Ixodes females
best conditions for attachment. Tick and flea removal
and counts were performed 48 h (±2 h) after each infest-
ation. Ticks were classified as dead or alive, attached or
unattached, and engorged or unengorged. Fleas were
classified as dead or alive and only live adult fleas were
counted. The personnel conducting tick/flea classifica-
tion and tick/flea counts were blinded to the treatment
status of each dog.
Efficacy evaluation
The statistical analysis was performed using the software
package SAS® (SAS Institute Inc., Cary, NC, USA, re-
lease 9.2). The individual dog was the experimental unit
in all statistical calculations. Data from each tick and flea
count time point were analysed separately.
The percentage of efficacy against ticks and fleas was
calculated for each treatment group at each assessment
time point using geometric means with Abbott’s formula:
Efficacy (%) = 100 x (MC - MT) / MC, where MC was
the mean number of total live female ticks (attached and
free) or total adult live fleas on untreated control dogs
(water-immersed or shampooed group) and MT the
mean number of total live female ticks (attached and
free) or total adult live fleas on treated dogs (water-
immersed or shampooed group). In case of zero counts,









Significant differences were assessed between the log-
counts of live ticks and fleas in each treatment group at
each assessment time point and the log-counts of the cor-
responding untreated control group. Study groups were
compared using a linear mixed model including study
group as a fixed effect and block as a random effect. The
two-sided level of significance was declared when p ≤ 0.05.
Results
No treatment-related adverse event was observed in any
of the 16 dogs treated with fluralaner spot-on solution
during the study.
An adequate tick infestation (at least 6 out of 8 ani-
mals with a tick attachment rate > 25 %) was achieved in
both control groups on all infestation time points, ex-
cept in the shampooed control animals on day 58. At
this time point, 5 of the 8 control animals had a tick at-
tachment rate >25 %, and the individual tick attachment
rate ranged between 5.0 and 51.5 %. However, as this
only occurred on one occasion and involved only one
dog, the tick infestations were considered to be suffi-
ciently vigorous to provide a valid result. The efficacy
against ticks at each assessment time point was 99.7-
100 % after a single topical fluralaner spot-on solution
administration in the water-immersed group. In the
shampooed group, the efficacy against ticks at each as-
sessment time point was 99.2-100 % after a single topical
fluralaner spot-on solution treatment. Tick reduction in
both treatment groups was significant at all assessment
time points (p < 0.0001) (Table 1).
An adequate flea infestation (at least 6 out of 8 ani-
mals with a flea infestation rate > 50 %) was achieved in
both control groups on all infestation time points, ex-
cept in the shampooed control animals on day 6. At this
time point, 4 of the 8 control animals had a flea infest-
ation rate >50 %, and the individual flea infestation rate
ranged from 6 to 97 %. The lower infestation rate in these
dogs may have been caused by the dogs being shampooed
1 day before the flea infestation on day 4. At all other in-
festation time points the dogs were shampooed 7 days be-
fore flea infestation. However, as this only occurred on
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one occasion, the flea infestations were considered to be
sufficiently vigorous to provide a valid result. The efficacy
against fleas at each assessment time point was 100 %
after a single topical fluralaner spot-on solution adminis-
tration in the water-immersed and in the shampooed
group. Flea reduction in both treatment groups was sig-
nificant at all assessment time points (p < 0.0001)
(Table 2).
Discussion
Results from this study demonstrate that a single topical
fluralaner spot-on solution administration remains
highly effective against ticks and fleas for 12 weeks fol-
lowing treatment even in the face of repeated water-
immersion (simulating swimming of the dog) or sham-
pooing of the dog. Coat wetting is inevitable for dogs,
and dogs that spend a lot of time outdoors are likely to
have an increased level of water exposure including
swimming and rainfall. Additionally, bathing and sham-
pooing dogs for cosmetic and hygienic reasons is a com-
mon practice. Therefore, it is important that a topically
applied, long-acting ectoparasiticide retains its efficacy over
the complete re-treatment interval even in the face of
water-immersion or shampooing. This study showed that
either soaking with water or shampooing the dog with a
foaming micro-emulsion and unscented shampoo without
any insecticide up to a total of 4 times within 12 weeks, had
no impact on the duration and level of efficacy of fluralaner
spot-on solution over the 12-week recommended re-
treatment interval. Therefore, veterinarians and pet owners
do not need to be concerned that tick and flea efficacy
will diminish, if a dog treated with fluralaner spot-on
solution goes swimming, gets exposed to rain or will
be shampooed.
The first water-immersion or shampooing in this study
was performed 3 days after the fluralaner spot-on solu-
tion treatment, followed by a tick and flea infestation
just 1 day later, with an efficacy of 100 % against both
parasites. Therefore, water-immersion and shampooing
at day 3 following topical administration had no impact
on the level of efficacy. Pharmacokinetic data show that
fluralaner rapidly crosses the dermis following topical
administration and suggest that water-immersion or
shampooing will likely not reduce the post-treatment
tick and flea efficacy if this occurs earlier than 3 days
post-treatment [9].
Table 1 Mean tick counts and efficacy (%) after a single topical administration of fluralaner spot-on solution followed by water-immersion
or shampooing of dogs before each tick infestation
Assessment time pointsa Study day 6 Study day 30 Study day 58 Study day 86
Study Group Fluralaner Control Fluralaner Control Fluralaner Control Fluralaner Control
Water-immersion Meanb tick counts (n) 0.0 27.5 0.0 29.7 0.0 19.3 0.1 28.7
Count range (n) 0 18–38 0 21–35 0 9d–39 0–1 21–32
Efficacy (%) 100c 100c 100c 99.7c
Shampooing Meanb tick counts (n) 0.0 28.9 0.0 28.5 0.0 14.3 0.2 29.6
Count range (n) 0 20–39 0 20–37 0 3e–31 0–4 21–41
Efficacy (%) 100c 100c 100c 99.2c
aAssessment of ticks 48 h (±2 h) after treatment or re-infestation following treatment
bGeometric mean
cLog-counts of live ticks from the treatment group were significantly different (p ≤ 0.05) from log-counts of the respective untreated control group
d7 out of 8 dogs adequately infested
e5 out of 8 dogs adequately infested
Table 2 Mean flea counts and efficacy (%) after a single topical administration of fluralaner spot-on solution followed by water-immersion
or shampooing of dogs before each flea infestation
Assessment time pointsa Study day 6 Study day 30 Study day 58 Study day 86
Study Group Fluralaner Control Fluralaner Control Fluralaner Control Fluralaner Control
Water-immersion Meanb flea counts (n) 0.0 92.2 0.0 88.6 0.0 88.3 0.0 81.7
Count range (n) 0 85–99 0 78–101 0 79–100 0 65–96
Efficacy (%) 100c 100c 100c 100c
Shampooing Meanb flea counts (n) 0.0 34.5 0.0 80.2 0.0 87.7 0.0 89.1
Count range (n) 0 6d–97 0 55–101 0 78–101 0 73–99
Efficacy (%) 100c 100c 100c 100c
aAssessment for fleas 48 h (±2 h) after treatment or re-infestation following treatment
bGeometric mean
cLog-counts of live fleas from the treatment group were significantly different (p ≤ 0.05) from log-counts of the respective untreated control group
d4 out of 8 dogs adequately infested
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It is likely that any impact of water-immersion or
shampooing on efficacy will be a general effect and will
not be specific to any particular ectoparasite species. No
negative effect on efficacy of either water-immersion or
shampooing was observed for the test parasites chosen
(I. ricinus or C. felis). Consequently, it is expected that
there will be no negative impact on the efficacy of any
other ectoparasite known to be sensitive to fluralaner.
Conclusions
Neither water-immersion nor shampooing after single
topical administration of fluralaner spot-on solution had
an impact on the excellent tick and flea efficacy over the
12-week recommended re-treatment interval.
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